As with medical marijuana, Vertex Pharmaceuticals' new pain drug is a non-opioid and therefore non-addictive. Next: Access Our New, Shockingly Simple 'Alert System' Unlike opioids, Journavx blocks ...

OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for ...

The Italian healthcare industry, encompassing over 4,500 companies generating an annual turnover of €17 billion, continues to drive progress in pharmaceutical research and medical machinery.

Innate Pharma (IPHA) announced the first patient was dosed in its Phase 1 study, investigating the safety and tolerability of IPH4502, an Antibody-Drug Conjugate, in patients with advanced solid ...

Performances associated with the festival will kick off Thursday, January 23th with a free Community Jazz Showcase at 7:00 p.m. at the Long Center for the Performing arts in Lafayette, Indiana, ...

We recently compiled a list of the 14 Best 52-Week High Stocks To Buy According to Analysts. In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against ...

It was easy to speculate that the Phoenix Suns had their eye on Jimmy Butler when they completed a trade with the Utah Jazz on Tuesday, but such suggestions reportedly may have been premature.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...